Morge X - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Phase I clinical trial and pharmacokinetic evaluation of doxorubicin carried by polyisohexylcyanoacrylate nanoparticles.

Kattan J, Droz JP, Couvreur P, Marino JP, Boutan-Laroze A, Rougier P, Brault P, Vranckx H, Grognet JM, Morge X, et al. Kattan J, et al. Among authors: morge x. Invest New Drugs. 1992 Aug;10(3):191-9. doi: 10.1007/BF00877245. Invest New Drugs. 1992. PMID: 1428729 Clinical Trial.

Enzyme immunoassays for a new angiotensin-converting enzyme inhibitor, zabicipril, and its active metabolite in human plasma: application to pharmacokinetic studies.

Ezan E, Morge X, Lelièvre E, Créminon C, Piraube C, Grognet JM. Ezan E, et al. Among authors: morge x. Ther Drug Monit. 1993 Oct;15(5):448-54. doi: 10.1097/00007691-199310000-00015. Ther Drug Monit. 1993. PMID: 8249053

Disposition and metabolism of two acetylcholinesterase reactivators, pyrimidoxime and HI6, in rats submitted to organophosphate poisoning.

Garrigue H, Maurizis JC, Nicolas C, Madelmont JC, Godeneche D, Hulot T, Morge X, Demerseman P, Sentenac-Roumanou H, Veyre A. Garrigue H, et al. Among authors: morge x. Xenobiotica. 1990 Jul;20(7):699-709. doi: 10.3109/00498259009046886. Xenobiotica. 1990. PMID: 2146816

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Search Page

Filters